Pharsight

Drugs that contain Granisetron Hydrochloride

1. Kytril patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5952340 ROCHE Use of granisetron for the treatment of postoperative nausea and vomiting
Sep, 2016

(7 years ago)

Drug Exclusivity Drug Exclusivity Expiration
M(M-102) Apr 29, 2014

Market Authorisation Date: 17 September, 2004

Treatment: Post operative nausea and vomiting

Dosage: INJECTABLE;INJECTION

How can I launch a generic of KYTRIL before it's drug patent expiration?
More Information on Dosage

KYTRIL family patents

Family Patents